Archives May 2026

New Delhi,May 1 (BNP): In a major relief for millions of salaried employees and pensioners, the government is reportedly considering a sharp hike in the minimum pension under the Employees’ Pension Scheme (EPS-95). The current minimum pension of ₹1,000 per month may be increased to ₹7,500, according to recent reports.

The proposed revision comes amid growing demands from labour unions and pensioners’ associations, who have long argued that the present pension amount is inadequate in view of rising inflation and living costs. A parliamentary panel has also reportedly supported the move, and a final decision is expected soon.

In another significant development, the Employees’ Provident Fund Organisation (EPFO) is also working on enabling ATM-based withdrawals for Provident Fund (PF) accounts. This move is expected to make access to funds faster, easier, and more convenient for subscribers.

Reports suggest that under the proposed digital upgrade, members may be able to withdraw PF money directly through ATMs, similar to regular bank transactions, reducing delays in emergency fund access.

Additionally, EPFO is likely to maintain an 8.25% interest rate on EPF deposits for FY26, subject to final approval from the Finance Ministry.

If approved, these reforms would mark one of the biggest overhauls in EPFO services, offering higher retirement security and easier access to savings for crores of workers across India.

Philadelphia, PA – May 1 – Tendo on Thursday announced a new agreement with InfuCare Rx®, a national infusion services provider, to expand access to high-quality, cost-effective infusion therapy through the Tendo Marketplace.

Infusion therapy is a major cost driver across autoimmune and inflammatory disorders, as well as neurology, hematology, and immuno-oncology. This relationship supports Tendo Marketplace’s broader mission to support ambulatory care and bring new specialty clinical categories to employers, health plans, and patients—particularly in areas with high cost and complex care needs.

“By working with InfuCare Rx, we are proud to expand access to innovative infusion care models that improve affordability while enhancing the patient experience,” said Ben Maisano, SVP Strategy at Tendo. “This relationship strengthens our national network and helps employers and plan sponsors better navigate some of the most expensive specialty therapies in the US.”

InfuCare Rx provides comprehensive infusion services through a growing national footprint, including:

• 20+ infusion nursing offices and suites

• Nationwide nursing and home infusion services

• 300+ conditions treated

“We are excited to collaborate with Tendo to expand access to safe, high-quality infusion therapy in more convenient and cost-effective settings,” said Deven Patel, Founder and Chief Executive Officer at InfuCare Rx. “Together, we’re making it easier for patients to receive complex specialty treatments closer to home while helping payers and employers better manage specialty drug spending.”

InfuCare Rx enhances the infusion care experience by offering flexible care delivery options, including ambulatory clinics and in-home services. This approach supports cost-effective care while maintaining strong clinical oversight and improving convenience, reducing travel burden, and expanding access to specialty care nationwide.

“For patients undergoing ongoing infusion therapy, convenience and continuity of care make a meaningful difference,” said Mike Reese, VP Clinical Advocacy at Valenz. “Having access to trusted, home-based infusion options allows us to guide members toward high-quality care that fits their lives.”

The InfuCare Rx care delivery model includes standardized protocols and ongoing patient monitoring to support quality, safety, and outcomes across infusion therapies.

With the addition of InfuCare Rx, Tendo adds to its national infusion network for Tendo’s Marketplace, offering greater choice, value, and modern site-of-care options for patients and partners across the country.